These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 25168049)

  • 21. Management of patients with high gastrointestinal risk on antiplatelet therapy.
    Cryer B
    Gastroenterol Clin North Am; 2009 Jun; 38(2):289-303. PubMed ID: 19446259
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of proton pump inhibitors and dual antiplatelet therapy cessation on outcomes following percutaneous coronary intervention: Results From the PARIS Registry.
    Chandrasekhar J; Bansilal S; Baber U; Sartori S; Aquino M; Farhan S; Vogel B; Faggioni M; Giustino G; Ariti C; Colombo A; Chieffo A; Kini A; Saporito R; Michael Gibson C; Witzenbichler B; Cohen D; Moliterno D; Stuckey T; Henry T; Pocock S; Dangas G; Gabriel Steg P; Mehran R
    Catheter Cardiovasc Interv; 2017 Jun; 89(7):E217-E225. PubMed ID: 27650638
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Individualised PPI prescription in patients on combination antiplatelet therapy and upper gastrointestinal events after percutaneous coronary intervention: a cohort study.
    Häuptle R; Weilenmann D; Schneider T; Haile SR; Ammann P; Knellwolf C; Borovicka J
    Wien Med Wochenschr; 2012 Feb; 162(3-4):67-73. PubMed ID: 22476595
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The risk of lower gastrointestinal bleeding in low-dose aspirin users.
    Chen WC; Lin KH; Huang YT; Tsai TJ; Sun WC; Chuah SK; Wu DC; Hsu PI
    Aliment Pharmacol Ther; 2017 Jun; 45(12):1542-1550. PubMed ID: 28449186
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Randomised clinical trial: rabeprazole plus aspirin is not inferior to rabeprazole plus clopidogrel for the healing of aspirin-related peptic ulcer.
    Luo JC; Huang KW; Leu HB; Chen LC; Hou MC; Li CP; Lu CL; Lin HC; Lee FY; Lee SD
    Aliment Pharmacol Ther; 2011 Sep; 34(5):519-25. PubMed ID: 21726257
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk factors for gastrointestinal bleeding in patients with cerebral infarction after dual antiplatelet therapy.
    Huang J; Liao F; Tang J; Shu X
    Clin Neurol Neurosurg; 2023 Aug; 231():107802. PubMed ID: 37295199
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy and Safety of Proton-Pump Inhibitors in High-Risk Cardiovascular Subsets of the COGENT Trial.
    Vaduganathan M; Cannon CP; Cryer BL; Liu Y; Hsieh WH; Doros G; Cohen M; Lanas A; Schnitzer TJ; Shook TL; Lapuerta P; Goldsmith MA; Laine L; Bhatt DL;
    Am J Med; 2016 Sep; 129(9):1002-5. PubMed ID: 27143321
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk of major bleeding with concomitant dual antiplatelet therapy after percutaneous coronary intervention in patients receiving long-term warfarin therapy.
    DeEugenio D; Kolman L; DeCaro M; Andrel J; Chervoneva I; Duong P; Lam L; McGowan C; Lee G; DeCaro M; Ruggiero N; Singhal S; Greenspon A
    Pharmacotherapy; 2007 May; 27(5):691-6. PubMed ID: 17461704
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antiplatelet Therapy of Cilostazol or Sarpogrelate with Aspirin and Clopidogrel after Percutaneous Coronary Intervention: A Retrospective Cohort Study Using the Korean National Health Insurance Claim Database.
    Noh Y; Lee J; Shin S; Lim HS; Bae SK; Oh E; Kim GJ; Kim JH; Lee S
    PLoS One; 2016; 11(3):e0150475. PubMed ID: 26939062
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Proton-pump inhibitors can decrease gastrointestinal bleeding after percutaneous coronary intervention.
    Jiang Z; Wu H; Duan Z; Wang Z; Hu K; Ye F; Zhang Z
    Clin Res Hepatol Gastroenterol; 2013 Dec; 37(6):636-41. PubMed ID: 23684576
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Esomeprazole with clopidogrel reduces peptic ulcer recurrence, compared with clopidogrel alone, in patients with atherosclerosis.
    Hsu PI; Lai KH; Liu CP
    Gastroenterology; 2011 Mar; 140(3):791-8. PubMed ID: 21144850
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Outcomes with concurrent use of clopidogrel and proton-pump inhibitors: a cohort study.
    Ray WA; Murray KT; Griffin MR; Chung CP; Smalley WE; Hall K; Daugherty JR; Kaltenbach LA; Stein CM
    Ann Intern Med; 2010 Mar; 152(6):337-45. PubMed ID: 20231564
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relationship between cardiovascular outcomes and proton pump inhibitor use in patients receiving dual antiplatelet therapy after acute coronary syndrome.
    Hsiao FY; Mullins CD; Wen YW; Huang WF; Chen PF; Tsai YW
    Pharmacoepidemiol Drug Saf; 2011 Oct; 20(10):1043-9. PubMed ID: 21823195
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rationale and Design for a Randomized Comparison of Efficacy and Safety between Aspirin and Clopidogrel in Atrial Fibrillation Patients with Low Stroke Risk: CESAC-AF trial.
    Park SM; Jeong H; Jung MH; Hong KS; Hong MK; Bang CS; Kim CY
    Contemp Clin Trials; 2017 Sep; 60():51-55. PubMed ID: 28642210
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Does dual antiplatelet therapy always require gastroprotection? Gastroprotection with proton pump inhibitors is advisable for all patients who need dual antiplatelet therapy].
    Morini S; Zullo A
    G Ital Cardiol (Rome); 2010 Jun; 11(6):488-92; discussion 492. PubMed ID: 20922875
    [No Abstract]   [Full Text] [Related]  

  • 36. Lower GI bleeding is more common than upper among patients on dual antiplatelet therapy: long-term follow-up of a cohort of patients commonly using PPI co-therapy.
    Casado Arroyo R; Polo-Tomas M; Roncalés MP; Scheiman J; Lanas A
    Heart; 2012 May; 98(9):718-23. PubMed ID: 22523056
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk of drug-eluting stent thrombosis in patients receiving proton pump inhibitors.
    Sarafoff N; Sibbing D; Sonntag U; Ellert J; Schulz S; Byrne RA; Mehilli J; Schömig A; Kastrati A
    Thromb Haemost; 2010 Sep; 104(3):626-32. PubMed ID: 20664905
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gastrointestinal bleeding after percutaneous coronary intervention.
    Tanigawa T; Watanabe T; Nadatani Y; Otani K; Machida H; Okazaki H; Yamagami H; Watanabe K; Tominaga K; Fujiwara Y; Arakawa T
    Digestion; 2011; 83(3):153-60. PubMed ID: 21266809
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence, Management, and Long-Term (6-Year) Outcomes of Atrial Fibrillation Among Patients Receiving Drug-Eluting Coronary Stents.
    Choi HI; Ahn JM; Kang SH; Lee PH; Kang SJ; Lee SW; Kim YH; Lee CW; Park SW; Park DW; Park SJ
    JACC Cardiovasc Interv; 2017 Jun; 10(11):1075-1085. PubMed ID: 28527773
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Upper gastrointestinal lesions in patients receiving clopidogrel anti-platelet therapy.
    Tsai TJ; Lai KH; Hsu PI; Lin CK; Chan HH; Yu HC; Wang HM; Lin KH; Wang KM; Chang SN; Liu CP; Hsiao SH; Huang HR; Lin CH; Tsay FW
    J Formos Med Assoc; 2012 Dec; 111(12):705-10. PubMed ID: 23265750
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.